Stay in Step With Treatments for Restless Legs Syndrome

July 2025

Dopamine agonists (ropinirole, etc) are no longer first-line for restless legs syndrome (RLS)...according to the Am Acad of Sleep Medicine.

Prescribers typically reach for these to help RLS symptoms quickly.

Now recent guidelines conditionally recommend AGAINST their use unless patients are prioritizing short-term benefits over long-term risks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote